Core Insights - BellRing Brands, Inc. is under investigation for potential violations of federal securities laws, as announced by Bleichmar Fonti & Auld LLP [1] - The company's sales growth may have been artificially inflated due to temporary trade inventory loading rather than sustainable consumer demand [2] Company Performance - BellRing Brands operates in the convenient nutrition category, with primary brands including Premier Protein and Dymatize, which offer ready-to-drink protein shakes and powders [2] - The company reported that Premier Protein achieved an all-time high in household penetration and strong demand across all channels, driven by distribution expansion and promotional activities [2] Stock Market Reaction - On May 5, 2025, BellRing disclosed that key retailers reduced their inventory levels, which would negatively impact growth in Q3 2025, leading to a stock price drop of $13.96, or over 18%, from $77.34 to $63.38 per share [3] - Following disappointing quarterly consumption results for Premier Protein RTD Shakes on August 4, 2025, the stock fell by $17.46, nearly 33%, from $53.64 to $36.18 per share [4]

Core Viewpoint - James Hardie Industries plc is under investigation for potential violations of federal securities laws, following a significant decline in North American sales attributed to temporary inventory loading rather than sustainable customer demand [1][3]. Company Overview - James Hardie is a producer and marketer of high-performance fiber cement and fiber gypsum building solutions, primarily used in external siding for the residential building industry in the U.S. and Canada [2]. Sales Performance - The company claimed that its "fast[]-growing customers" were a key aspect of its competitive positioning, asserting strong North American business results [3]. - However, it was revealed that North American net sales declined by 12% in fiscal Q1 2026, driven by lower volumes as customers adjusted inventory levels [4]. Stock Market Reaction - Following the earnings report on August 19, 2025, which disclosed the sales decline and expected continued inventory destocking, James Hardie's stock price fell by $9.79 per share, a decrease of over 34%, from $28.43 to $18.64 [4].

Core Viewpoint - A class action securities lawsuit has been filed against KinderCare Learning Companies, Inc. due to alleged securities fraud affecting investors who purchased shares during the October 2024 initial public offering [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors adversely affected by alleged securities fraud related to KinderCare Learning Companies, Inc. [2] - The complaint alleges that KinderCare concealed incidents of child abuse, neglect, and harm at its facilities, failed to provide high-quality care, and did not meet minimum standards in the child care industry [3]. - As a result of these issues, KinderCare is said to have faced undisclosed risks of lawsuits, regulatory actions, negative publicity, reputational damage, and business loss [3]. Group 2: Next Steps for Investors - Investors who suffered losses in KinderCare Learning Companies, Inc. during the relevant timeframe have until October 14, 2025, to request appointment as lead plaintiff [4]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securing compensation for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

LOS ANGELES, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 2, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR MOLINA INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO ...

Core Insights - Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. regarding potential securities fraud or unlawful business practices by the company and its officers or directors [1] - On October 6, 2025, Skye announced that its Phase 2a study of nimacimab did not meet its primary endpoint of weight loss compared to placebo, leading to a significant drop in stock price [1] Company Overview - Skye Bioscience, Inc. is a publicly traded company on NASDAQ under the ticker SKYE [1] - The company is involved in the development of nimacimab, a peripherally-restricted CB1 inhibitor antibody [1] Financial Impact - Following the announcement of the study results, Skye's stock price fell by $2.85 per share, representing a 60% decrease, closing at $1.90 per share on October 6, 2025 [1]

Core Insights - Pomerantz LLP is investigating claims on behalf of investors of Rezolve AI PLC regarding potential securities fraud or unlawful business practices [1] - A report by Fuzzy Panda Research alleges that Rezolve misrepresents its AI capabilities and revenue growth, claiming it is primarily a mobile phone-related tech company [1] - Following the allegations, Rezolve's stock price dropped by $0.97, or 16.3%, closing at $4.98 per share [1] Group 1 - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having a history of recovering multimillion-dollar damages for victims of securities fraud [2] - The investigation focuses on whether Rezolve and its officers/directors engaged in fraudulent activities [1] - The Fuzzy Panda report specifically criticizes the CEO's history of false statements and the company's acquisition strategy of failing AI startups [1] Group 2 - The stock price decline occurred over two trading sessions following the release of the Fuzzy Panda report [1] - The investigation is part of a broader effort to protect investors' rights against corporate misconduct [2] - Pomerantz LLP has been active in the field for over 85 years, continuing the legacy of its founder in fighting for victims of corporate fraud [2]

Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to disappointing financial results and misleading statements made by the company's leadership during the class period from February 26, 2025, to August 8, 2025 [1][4]. Financial Performance - On August 8, 2025, C3.ai announced preliminary financial results for Q1 of fiscal 2026 that were below expectations and reduced its revenue guidance for the full fiscal year 2026, attributing this to a reorganization with new leadership and the health issues of its CEO [2][4]. Stock Market Reaction - Following the announcement of disappointing results, C3.ai's stock price dropped by $5.66, or 25.6%, closing at $16.47 per share on August 11, 2025, which negatively impacted investors [3]. Allegations in the Lawsuit - The class action complaint alleges that C3.ai's leadership made materially false and misleading statements and failed to disclose significant adverse facts about the company's business and prospects. Key allegations include: 1. The company's optimistic growth and earnings reports were overly reliant on the CEO's health and effectiveness, which were not as robust as claimed [4]. 2. The CEO had not sufficiently recovered from health issues to fulfill his role effectively, contrary to repeated assurances [4]. 3. Positive statements made by the leadership lacked a reasonable basis and were materially misleading throughout the class period [4]. Legal Proceedings - Investors who purchased C3.ai securities during the class period have until October 21, 2025, to file a lead plaintiff motion in the class action lawsuit [1][5].

, /PRNewswire/ --Â The Law Offices of Frank R. Cruz announces that investors with losses related to KinderCare Learning Companies, Inc. ("KinderCare" or the "Company") (NYSE:Â KLC) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN KINDERCARE LEARNING COMPANIES, INC. (KLC), CLICK HEREÂ BEFORE OCTOBER 14, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Â What Is The Lawsuit About? The complaint filed all ...

RADNOR, Pa., Oct. 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Firefly Aerospace Inc. (NASDAQ: FLY) (“Firefly Aerospace”). On September 22, 2025, Firefly Aerospace reported its financial results for the second quarter of fiscal year 2025 – Firefly Aerospace’s initial quarterly results as a public company since its initial public offering the prior month. ...

LOS ANGELES, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 20, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired PubMatic, Inc. (“PubMatic” or the “Company”) (NASDAQ: PUBM) securities between February 27, 2025 and August 11, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR PUBMATIC INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS T ...